Skip to main content
. 2017 Aug 11;7(8):e016224. doi: 10.1136/bmjopen-2017-016224

Table 2.

Association (β 95% CI) between antidepressant use and annual weight gain

Non-user 1–2 prescriptions/year >2 prescriptions/year p Value
Any antidepressant
  n 1934 188 212
 Baseline weight (kg), mean (SD) 80.0 (17.0) 77.1 (16.5) 81.3 (19.1)
 Follow-up weight (kg), mean (SD) 80.6 (17.3) 78.0 (17.2) 82.5 (19.6)
  Annual weight change (kg), mean (SD) 0.12 (1.32) 0.18 (1.54) 0.28 (1.99)
   Model 1* Ref 0.15(−0.06 to 0.36) 0.22 (0.02 to 0.42) 0.022
   Model 2† Ref 0.18(−0.04 to 0.40) 0.25 (0.04 to 0.46) 0.009
   Model 3‡ Ref 0.11(−0.11 to 0.34) 0.22 (0.00 to 0.44) 0.044
SSRIs
  n 2109 114 111
 Baseline weight (kg), mean (SD) 79.8 (17.0) 79.7 (18.2) 82.2 (19.1)
 Follow-up weight (kg), mean (SD) 80.3 (17.3) 81.2 (18.0) 84.9 (21.2)
 Annual weight change (kg), mean (SD) 0.11 (1.33) 0.38 (2.11) 0.61 (1.89)
   Model 1* Ref 0.30 (0.04 to 0.57) 0.53 (0.27 to 0.80) <0.001
   Model 2† Ref 0.30 (0.03 to 0.58) 0.58 (0.30 to 0.85) <0.001
   Model 3‡ Ref 0.30 (0.01 to 0.58) 0.48 (0.20 to 0.76) <0.001
TCAs
  n 2212 79 43
 Baseline weight (kg), mean (SD) 80.1 (17.2) 76.3 (17.8) 77.3 (15.9)
 Follow-up weight (kg), mean (SD) 80.8 (17.5) 75.5 (17.3) 77.3 (16.4)
 Annual weight change (kg), mean (SD) 0.16 (1.40) −0.13 (1.61) −0.01 (1.32)
   Model 1* Ref −0.12(−0.44 to 0.19) 0.06(−0.36 to 0.49) 0.717
   Model 2† Ref −0.11(−0.44 to 0.22) 0.05(−0.39 to 0.50) 0.704
   Model 3‡ Ref 0.02(−0.31 to 0.36) 0.03(−0.46 to 0.52) 0.908
Other antidepressants
  n 2210 57 67
 Baseline weight (kg), mean (SD) 79.8 (17.0) 80.0 (18.7) 82.9 (20.5)
 Follow-up weight (kg), mean (SD) 80.4 (17.4) 81.3 (17.6) 83.4 (21.2)
 Annual weight change (kg), mean (SD) 0.14 (1.37) 0.35 (1.88) 0.12 (2.08)
   Model 1* Ref 0.23(−0.13 to 0.60) −0.04(−0.38 to 0.29) 0.844
   Model 2† Ref 0.32(−0.05 to 0.70) −0.01(−0.36 to 0.35) 0.505
   Model 3‡ Ref 0.42 (0.03 to 0.80) −0.19(−0.56 to 0.19) 0.926

*Model 1 adjusted for age and gender.

†Model 2 further adjusted for baseline income, smoking, physical activity, follow-up duration.

‡Model 3 further adjusted for depression status at baseline and follow-up, dietary patterns (continuous).

SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.